Titre : Produits de contraste

Produits de contraste : Questions médicales fréquentes

{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Produits de contraste : Questions médicales les plus fréquentes", "headline": "Produits de contraste : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Produits de contraste : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-21", "dateModified": "2026-02-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Produits de contraste" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Utilisations spécialisées de produits chimiques", "url": "https://questionsmedicales.fr/mesh/D020313", "about": { "@type": "MedicalCondition", "name": "Utilisations spécialisées de produits chimiques", "code": { "@type": "MedicalCode", "code": "D020313", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D27.720" } } }, "about": { "@type": "MedicalCondition", "name": "Produits de contraste", "alternateName": "Contrast Media", "code": { "@type": "MedicalCode", "code": "D003287", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Andreas H Mahnken", "url": "https://questionsmedicales.fr/author/Andreas%20H%20Mahnken", "affiliation": { "@type": "Organization", "name": "Department of Diagnostic and Interventional Radiology, Marburg University Hospital, Marburg, Germany." } }, { "@type": "Person", "name": "Aart J van der Molen", "url": "https://questionsmedicales.fr/author/Aart%20J%20van%20der%20Molen", "affiliation": { "@type": "Organization", "name": "Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands." } }, { "@type": "Person", "name": "Ilona A Dekkers", "url": "https://questionsmedicales.fr/author/Ilona%20A%20Dekkers", "affiliation": { "@type": "Organization", "name": "Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands." } }, { "@type": "Person", "name": "Remy W F Geenen", "url": "https://questionsmedicales.fr/author/Remy%20W%20F%20Geenen", "affiliation": { "@type": "Organization", "name": "Department of Radiology, Northwest Clinics, Alkmaar, The Netherlands." } }, { "@type": "Person", "name": "Marie-France Bellin", "url": "https://questionsmedicales.fr/author/Marie-France%20Bellin", "affiliation": { "@type": "Organization", "name": "Department of Radiology, University Paris Saclay, AP-HP, University Hospital Bicêtre, BioMaps, Le Kremlin-Bicêtre, France." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Clinical features and risk factors of iodinated contrast media (ICM)-induced anaphylaxis.", "datePublished": "2023-05-10", "url": "https://questionsmedicales.fr/article/37187078", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ejrad.2023.110880" } }, { "@type": "ScholarlyArticle", "name": "Delayed hypersensitivity reactions to iodinated contrast media: A diagnostic approach by skin tests.", "datePublished": "2023-07-02", "url": "https://questionsmedicales.fr/article/37394777", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/cod.14372" } }, { "@type": "ScholarlyArticle", "name": "Key Considerations regarding the Renal Risks of Iodinated Contrast Media: The Nephrologist's Role.", "datePublished": "2023-09-27", "url": "https://questionsmedicales.fr/article/37757781", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000533282" } }, { "@type": "ScholarlyArticle", "name": "Skin Test Reactivity Patterns in Patients Allergic to Iodinated Contrast Media: A Refined View.", "datePublished": "2023-10-30", "url": "https://questionsmedicales.fr/article/39056227", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jaip.2023.10.040" } }, { "@type": "ScholarlyArticle", "name": "Exploring Factors Affecting the Occurrence of Hypersensitivity Reactions Induced by Nonionic Iodine Contrast Media.", "datePublished": "2023-05-26", "url": "https://questionsmedicales.fr/article/37114401", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jcph.2256" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Actions chimiques et utilisations", "item": "https://questionsmedicales.fr/mesh/D020164" }, { "@type": "ListItem", "position": 3, "name": "Utilisations spécialisées de produits chimiques", "item": "https://questionsmedicales.fr/mesh/D020313" }, { "@type": "ListItem", "position": 4, "name": "Produits de contraste", "item": "https://questionsmedicales.fr/mesh/D003287" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Produits de contraste - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Produits de contraste", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-04-30", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Produits de contraste", "description": "Quels sont les types de produits de contraste ?\nComment les produits de contraste sont-ils administrés ?\nQuel est le rôle des produits de contraste en IRM ?\nLes produits de contraste sont-ils nécessaires pour tous les examens ?\nQuels examens nécessitent souvent des produits de contraste ?", "url": "https://questionsmedicales.fr/mesh/D003287?page=2#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Produits de contraste", "description": "Quels effets secondaires peuvent survenir ?\nComment reconnaître une réaction allergique ?\nLes produits de contraste peuvent-ils causer des douleurs ?\nQuels symptômes indiquent une réaction grave ?\nLes produits de contraste peuvent-ils provoquer des nausées ?", "url": "https://questionsmedicales.fr/mesh/D003287?page=2#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Produits de contraste", "description": "Comment prévenir les réactions allergiques ?\nLes patients à risque doivent-ils éviter les produits de contraste ?\nQuelles précautions avant une injection de produit de contraste ?\nLes femmes enceintes peuvent-elles utiliser des produits de contraste ?\nComment informer le personnel médical des allergies ?", "url": "https://questionsmedicales.fr/mesh/D003287?page=2#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Produits de contraste", "description": "Comment traiter une réaction allergique aux produits de contraste ?\nQue faire en cas de douleur après l'injection ?\nLes patients peuvent-ils éviter les produits de contraste ?\nComment prévenir les effets secondaires ?\nLes produits de contraste peuvent-ils être remplacés par d'autres méthodes ?", "url": "https://questionsmedicales.fr/mesh/D003287?page=2#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Produits de contraste", "description": "Quelles sont les complications possibles des produits de contraste ?\nLes produits de contraste peuvent-ils affecter les reins ?\nComment gérer une néphropathie induite par les produits de contraste ?\nLes complications sont-elles fréquentes ?\nQuels signes indiquent une complication grave ?", "url": "https://questionsmedicales.fr/mesh/D003287?page=2#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Produits de contraste", "description": "Qui est à risque de réactions allergiques ?\nLes patients diabétiques sont-ils plus à risque ?\nQuel rôle joue l'âge dans les risques liés aux produits de contraste ?\nLes antécédents familiaux influencent-ils le risque ?\nLes patients avec maladies rénales chroniques sont-ils à risque ?", "url": "https://questionsmedicales.fr/mesh/D003287?page=2#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Quels sont les types de produits de contraste ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux types incluent les agents iodés, les agents à base de gadolinium et les agents à base de baryum." } }, { "@type": "Question", "name": "Comment les produits de contraste sont-ils administrés ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être administrés par voie intraveineuse, orale ou rectale selon l'examen." } }, { "@type": "Question", "name": "Quel est le rôle des produits de contraste en IRM ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Ils améliorent le contraste des tissus et des vaisseaux sanguins, facilitant le diagnostic." } }, { "@type": "Question", "name": "Les produits de contraste sont-ils nécessaires pour tous les examens ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, leur utilisation dépend du type d'examen et des structures à visualiser." } }, { "@type": "Question", "name": "Quels examens nécessitent souvent des produits de contraste ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les tomodensitométries (CT) et les IRM en sont des exemples courants." } }, { "@type": "Question", "name": "Quels effets secondaires peuvent survenir ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Des réactions allergiques, des nausées ou des sensations de chaleur peuvent se produire." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent éruption cutanée, démangeaisons, gonflement ou difficulté à respirer." } }, { "@type": "Question", "name": "Les produits de contraste peuvent-ils causer des douleurs ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains patients peuvent ressentir des douleurs au site d'injection ou des crampes abdominales." } }, { "@type": "Question", "name": "Quels symptômes indiquent une réaction grave ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme l'urticaire, l'œdème de Quincke ou un choc anaphylactique sont graves." } }, { "@type": "Question", "name": "Les produits de contraste peuvent-ils provoquer des nausées ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des nausées peuvent survenir après l'administration, mais elles sont généralement temporaires." } }, { "@type": "Question", "name": "Comment prévenir les réactions allergiques ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Un test cutané préalable peut être effectué pour évaluer le risque d'allergie." } }, { "@type": "Question", "name": "Les patients à risque doivent-ils éviter les produits de contraste ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients avec antécédents d'allergies doivent discuter des risques avec leur médecin." } }, { "@type": "Question", "name": "Quelles précautions avant une injection de produit de contraste ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Hydratation adéquate et information sur les allergies sont essentielles avant l'injection." } }, { "@type": "Question", "name": "Les femmes enceintes peuvent-elles utiliser des produits de contraste ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'utilisation doit être soigneusement évaluée par un médecin en raison des risques potentiels." } }, { "@type": "Question", "name": "Comment informer le personnel médical des allergies ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les patients doivent toujours signaler leurs allergies et antécédents médicaux avant l'examen." } }, { "@type": "Question", "name": "Comment traiter une réaction allergique aux produits de contraste ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement peut inclure des antihistaminiques ou des corticostéroïdes selon la gravité." } }, { "@type": "Question", "name": "Que faire en cas de douleur après l'injection ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Appliquer de la glace et prendre des analgésiques en cas de douleur persistante." } }, { "@type": "Question", "name": "Les patients peuvent-ils éviter les produits de contraste ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des alternatives existent, comme les examens sans contraste, selon le cas clinique." } }, { "@type": "Question", "name": "Comment prévenir les effets secondaires ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Informer le médecin des allergies et des antécédents médicaux peut aider à prévenir les effets indésirables." } }, { "@type": "Question", "name": "Les produits de contraste peuvent-ils être remplacés par d'autres méthodes ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des techniques comme l'échographie ou l'IRM sans contraste peuvent être utilisées." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des produits de contraste ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des réactions allergiques, des lésions rénales et des infections." } }, { "@type": "Question", "name": "Les produits de contraste peuvent-ils affecter les reins ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, en particulier chez les patients ayant une fonction rénale altérée, le risque est accru." } }, { "@type": "Question", "name": "Comment gérer une néphropathie induite par les produits de contraste ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une hydratation adéquate et un suivi médical sont essentiels pour gérer cette complication." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les complications graves sont rares, mais des effets indésirables bénins peuvent survenir." } }, { "@type": "Question", "name": "Quels signes indiquent une complication grave ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des signes comme une douleur intense, des difficultés respiratoires ou des éruptions cutanées doivent alerter." } }, { "@type": "Question", "name": "Qui est à risque de réactions allergiques ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies ou d'asthme sont plus à risque." } }, { "@type": "Question", "name": "Les patients diabétiques sont-ils plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent avoir un risque accru de complications rénales après l'utilisation de produits de contraste." } }, { "@type": "Question", "name": "Quel rôle joue l'âge dans les risques liés aux produits de contraste ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes âgées peuvent avoir une fonction rénale diminuée, augmentant le risque de complications." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'allergies peuvent augmenter le risque de réactions aux produits de contraste." } }, { "@type": "Question", "name": "Les patients avec maladies rénales chroniques sont-ils à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont particulièrement vulnérables aux effets néfastes des produits de contraste." } } ] } ] }

Sources (8728 au total)

Clinical features and risk factors of iodinated contrast media (ICM)-induced anaphylaxis.

To evaluate the clinical features and risk factors of iodinated contrast media (ICM)-induced anaphylaxis.... This retrospective study included all patients undergoing contrast-enhanced computed tomography (CT) with intravenous ICM administration (iopamidol, iohexol, iomeprol, iopromide, ioversol) at our hosp... Of the 76,194 ICM administrations (44,099 men [58 %] and 32,095 women; age, median, 68 years) to 27, 696 patients, anaphylaxis occurred in 45 cases in 45 different patients (0.06 % of administration a... The overall incidence of anaphylaxis due to ICM was very low. More than half of the cases had no risk factors for ADRs and had no ADRs on past ICM administration, although the ICM type was associated ...

Delayed hypersensitivity reactions to iodinated contrast media: A diagnostic approach by skin tests.

Adverse drug reactions to iodinated contrast media (ICM) have risen due to their increasing use in x-ray-based imaging modalities. Delayed hypersensitivity reactions are mainly caused by nonionic mono... To prospectively evaluate the usefulness of skin tests in delayed hypersensitivity reactions to ICM and to evaluate the tolerability of iobitridol, a monomeric nonionic low osmolality compound, as a p... Patients with delayed hypersensitivity reactions to ICM referred to us from 2020 to 2022 were prospectively enrolled in the study. All patients underwent patch test and, if negative, intradermal test ... A total of 37 patients (females 24, 64.9%) were enrolled in the study. Iodixanol and iomeprol were the most frequently involved ICM (48.5% and 35.2%, respectively); 62.2% of patients presented maculop... In at least half of patients, delayed-type hypersensitivity was demonstrated by skin tests, particularly by patch test. This diagnostic approach resulted simple, cost-effective and safe, not only to c...

Key Considerations regarding the Renal Risks of Iodinated Contrast Media: The Nephrologist's Role.

The administration of iodinated contrast medium during diagnostic and therapeutic procedures has always been associated with the fear of causing acute kidney injury (AKI) or an exacerbation of chronic... A literature review on contrast-induced (CI)-AKI risk mitigation strategies was performed, focussing on the recognition of individual risk factors and on the most recent evidence regarding prophylaxis... Nephrologists can contribute significantly in the CI-AKI context, from the early stages of the decision-making process to stratifying patients by risk, individualising prophylaxis measures based on th...

Skin Test Reactivity Patterns in Patients Allergic to Iodinated Contrast Media: A Refined View.

Two-dimensional (2D) classifications of iodinated contrast media (ICM) are insufficient to explain the observed skin test (ST) reactivity patterns in patients with drug hypersensitivity reactions (DHR... To refine the current view on allergic DHRs to ICM by analyzing ST reactivity patterns in patients with previous reactions to ICM.... Patients with a history of DHR to ICM and positive STs, who presented at the University Hospital of Montpellier between 2004 and 2022, were included in the study. The relative difference between every... A total of 181 patients were included in the study. Odds ratio analysis identified significant associations between classical cross-reactive ICM, such as iohexol-ioversol, iohexol-iomeprol, iomeprol-i... Current chemical (2D) classifications cannot explain all observed ST reactivity patterns. Whether the 3D structure can be integrated into the current classifications to interpret the observed ST react...

Contrast media-induced nephropathy in Tunisia: prospective case-control study with cardio-nephrological monitoring.

vascular opacification using iodinated contrast media (ICM) is often the primary diagnostic and therapeutic approach. However, the risk of post-injection nephrotoxicity of ICM is significantly higher ... our prospective study involved 158 patients who underwent coronary angiography or angioplasty at the cardiology department between December 2017 and May 2018. Two types of ICM were used in our study: ... the mean age of our patients was 60 ± 11 years (range: 29-82), with a predominance of men 63.9% (n=101). The most common cardiovascular risk factors were tobacco (36.1%, n = 57), diabetes (48.1%, n =7... the most effective approach for CMIN is prevention, which focuses on addressing modifiable risk factors to minimize the risk especially in patients with pre-existing renal failure....

Safety and efficacy of prophylactic treatment for hyperthyroidism induced by iodinated contrast media in a high-risk population.

The use of iodinated contrast media (ICM) can lead to thyrotoxicosis, especially in patients with risk factors, such as Graves' disease, multinodular goiter, older age, and iodine deficiency. Although... We aimed to demonstrate the safety and efficacy of prophylactic treatment with sodium perchlorate and/or methimazole to prevent ICM-induced hyperthyroidism (ICMIH) in a population of high-risk cardiac... We performed a longitudinal retrospective study on 61 patients admitted to a tertiary-level cardiology unit for diagnostic and/or therapeutic ICM-procedures. We included patients with available record... Twenty-three (38%) of the 61 patients were given a prophylactic treatment. Thyroid function deteriorated after the administration of ICM in 9/61 patients (15%). These cases were associated with higher... Prophylactic treatment can prevent the onset of ICMIH in high-risk populations administered ICM. Prophylaxis is safe and effective in this setting, especially in cardiopathic patients. Prophylaxis wit...

Long-term effects of contrast media exposure on renal failure progression: a retrospective cohort study.

With the constant need for technique improvement for ensuring correct diagnoses and precise treatment, imaging examinations that use contrast media have become unavoidable and indispensable. However, ... This retrospective cohort study included patients with a definitive diagnosis of chronic kidney disease who visited medical institutions in Japan between April 2012 and December 2020. The cohort was d... After adjusting for patient background with propensity score matching, 333 patients each were included in both groups. The observation period was 5.3 ± 2.1 and 4.9 ± 2.2 years per case in the contrast... We were able to identify a clinical trend of successful measures for preventing adverse renal outcomes associated with contrast media exposure. However, increased frequency of contrast media exposure ...

Gadolinium-based contrast media does not improve the staging of neuroblastoma image-defined risk factors at diagnosis.

Neuroblastoma risk stratification relies on prognostic risk factors and image-defined risk factors (IDRFs). Evaluating neuroblastoma typically involves magnetic resonance imaging (MRI) with gadolinium... We reviewed baseline MRI scans of 50 children with abdominopelvic neuroblastomas confirmed by histopathology. Duplicate sets of images were created, with post-contrast T1-weighted sequences removed fr... Mean age of included children was 3.3 years (range: 0.01-14.9 years), and 20 [40%] were females. Mean tumor size was 5.7 cm in greatest axial diameter. Pre-contrast versus post-contrast MRI showed exc... Contrast does not improve tumor size measurement or radiologist agreement on the presence or absence of IDRFs or metastatic disease in children with newly diagnosed neuroblastoma....